Skip to main content
. 2022 Sep 12;13:951239. doi: 10.3389/fgene.2022.951239

TABLE 1.

Univariate and multivariate Cox regression analysis determined the independent prognostic performance of our risk score.

Univariate HR HR.95L HR.95H p value Multivariate HR HR.95L HR.95H p value
a Type 0.720494516 0.561649 0.924265 0.009888 a Type 0.777666 0.597662 1.011884 0.061204
b Gender 0.912138 0.594411 1.399697 0.673813 b Gender 1.12804 0.724577 1.756162 0.59371
c Age 4.376072 2.722401 7.034235 1.09E-09 c Age 3.47046 2.061005 5.843794 2.87E-06
d Cancer_status 39.2837 5.466809 282.2869 0.000264 d Cancer_status 33.08822 4.589435 238.5545 0.000517
e Grade 3.694602 2.280463 5.985662 1.10E-07 e Grade 2.007173 1.136654 3.54439 0.01633
f RiskScore 1.062957 1.048184 1.077939 1.23E-17 f RiskScore 1.036923 1.02053 1.053579 8.21E-06
a

Type: Astrocytoma, Oligoastrocytoma, Oligodendroglioma.

b

Gender: Female, Male.

c

Age: ≤41, >41.

d

Cancer_status: Tumor free, With tumor.

e

Grade: G2, G3.

f

RiskScore: risk score = 5.68460388028422 * ZBP1 + 5.58839133632066 * PLK1 + 6.382784047 * CFLAR + 3.560828639 * SQSTM1 + 3.541878806 * FADD.